These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38076440)

  • 21. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.
    Said A
    World J Gastroenterol; 2013 Dec; 19(48):9146-55. PubMed ID: 24409043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.
    Golabi P; Bush H; Stepanova M; Locklear CT; Jacobson IM; Mishra A; Trimble G; Erario M; Venkatesan C; Younossi I; Goodman Z; Younossi ZM
    Medicine (Baltimore); 2018 Aug; 97(31):e11518. PubMed ID: 30075518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful Treatment of Rapid Onset, Symptomatic de novo Non-alcoholic Steatohepatitis Following Liver Transplantation: A Case Report.
    Cuschieri JR; John BK; Miick R; Ortiz JA; Hashemi N
    J Clin Exp Hepatol; 2013 Mar; 3(1):70-4. PubMed ID: 25755474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of liver transplantation for non-B non-C liver cirrhosis and hepatocellular carcinoma.
    Nishio T; Ito T; Hata K; Taura K; Hatano E
    Ann Gastroenterol Surg; 2023 Jan; 7(1):42-52. PubMed ID: 36643372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Most Cases of Cryptogenic Cirrhosis May Be Nonobese Nonalcoholic Steatohepatitis - Risk Factors of Liver Steatosis After Liver Transplantation for Cryptogenic Cirrhosis: A Retrospective Study.
    Fukushima M; Miyaaki H; Sasaki R; Haraguchi M; Miuma S; Hara T; Soyama A; Hidaka M; Eguchi S; Nakao K
    Intern Med; 2023 May; 62(10):1415-1423. PubMed ID: 36171128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
    Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
    BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation.
    Satapathy SK; Tran QT; Kovalic AJ; Bontha SV; Jiang Y; Kedia S; Karri S; Mupparaju V; Podila PSB; Verma R; Maluf D; Mas V; Nair S; Eason JD; Bridges D; Kleiner DE
    Clin Transl Gastroenterol; 2021 Feb; 12(2):e00302. PubMed ID: 33555168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De Novo Malignancy After Living Donor Liver Transplantation: A Large Volume Experience.
    Tiwari A; Saigal S; Choudhary NS; Saha S; Rastogi A; Bhangui P; Saraf N; Srinivasan T; Yadav SK; Gautam D; Nundy S; Soin AS
    J Clin Exp Hepatol; 2020; 10(5):448-452. PubMed ID: 33029053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges.
    Dooghaie Moghadam A; Eslami P; Razavi-Khorasani N; Moazzami B; Zahedi-Tajrishi F; Farokhi E; Makhdoomi Sharabiani K; Mansour-Ghanaei A; Mehrvar A; Aghajanpoor Pasha M; Saeedi S; Iravani S
    Caspian J Intern Med; 2020; 11(4):346-354. PubMed ID: 33680375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic steatosis after liver transplantation: a systematic review and meta-analysis.
    Silva AC; Nogueira P; Machado MV
    Liver Transpl; 2023 Apr; 29(4):431-448. PubMed ID: 36735478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of patient survival following liver transplant in non-alcoholic steatohepatitis: A systematic review and meta-analysis.
    Minich A; Arisar FAQ; Shaikh NS; Herman L; Azhie A; Orchanian-Cheff A; Patel K; Keshavarzi S; Bhat M
    EClinicalMedicine; 2022 Aug; 50():101534. PubMed ID: 35812989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation.
    Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G
    Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation.
    Iacob S; Beckebaum S; Iacob R; Gheorghe C; Cicinnati V; Popescu I; Gheorghe L
    Front Nutr; 2021; 8():787430. PubMed ID: 35096933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual alcohol and metabolic-related liver disease: Results from a population of liver transplant patients.
    Erard D; Villeret F; Chouik Y; Guillaud O; Scoazec JY; Caussy C; Disse E; Boillot O; Hervieu V; Dumortier J
    Liver Int; 2024 Feb; 44(2):422-432. PubMed ID: 38010979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NAFLD and liver transplantation: Disease burden, current management and future challenges.
    Burra P; Becchetti C; Germani G
    JHEP Rep; 2020 Dec; 2(6):100192. PubMed ID: 33163950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival.
    Villeret F; Dharancy S; Erard D; Abergel A; Barbier L; Besch C; Boillot O; Boudjema K; Coilly A; Conti F; Corpechot C; Duvoux C; Faitot F; Faure S; Francoz C; Giostra E; Gugenheim J; Hardwigsen J; Hilleret MN; Hiriart JB; Houssel-Debry P; Kamar N; Lassailly G; Latournerie M; Pageaux GP; Samuel D; Vanlemmens C; Saliba F; Dumortier J
    Liver Int; 2022 Nov; 42(11):2428-2441. PubMed ID: 35924452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis.
    Doycheva I; Thuluvath PJ
    Transl Gastroenterol Hepatol; 2020; 5():38. PubMed ID: 32632389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.
    Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J
    Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful Outcome of Bariatric Surgery in Living Donor Liver Transplant Recipients With Multidisciplinary Approach: A Preliminary Experience.
    Singhal V; Dhampalwar S; Saigal S; Choudhary N; Saraf N; Chaudhary A; Soin A
    J Clin Exp Hepatol; 2021; 11(1):144-148. PubMed ID: 33679051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
    Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
    World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.